Argitalpenak (58) LETICIA GONZALEZ BLANCO argitalpenak

2024

  1. Anticholinergic load: A commonly neglected and preventable risk to cognition during schizophrenia treatment?

    Schizophrenia Research: Cognition, Vol. 37

  2. From gut to brain: A network model of intestinal permeability, inflammation, and psychotic symptoms in schizophrenia.

    European Neuropsychopharmacology, Vol. 79, pp. 32-37

  3. Impact of cognitive reserve in clinical, neurocognitive and lifestyle factors in chronic schizophrenia and early stages of schizophrenia

    Spanish Journal of Psychiatry and Mental Health

  4. Impacto del consumo de sustancias sobre la permeabilidad intestinal en pacientes con esquizofrenia

    Adicciones: Revista de socidrogalcohol, Vol. 36, Núm. 1, pp. 111-114

  5. Intestinal permeability and low-grade chronic inflammation in schizophrenia: A multicentre study on biomarkers. Rationale, objectives, protocol and preliminary results

    Spanish Journal of Psychiatry and Mental Health

  6. Lithium response in bipolar disorder: Epigenome-wide DNA methylation signatures and epigenetic aging

    European Neuropsychopharmacology, Vol. 85, pp. 23-31

  7. Platelet and white blood-cell-based ratios: Differential inflammatory markers of severe mental disorders?

    Spanish Journal of Psychiatry and Mental Health

  8. PsiOvi Staging Model for Schizophrenia (PsiOvi SMS): A New Internet Tool for Staging Patients with Schizophrenia

    European Psychiatry, Vol. 67, Núm. 1

2023

  1. Obstetric complications and genetic risk for schizophrenia: Differential role of antenatal and perinatal events in first episode psychosis

    Acta Psychiatrica Scandinavica

  2. Prevalence of psychological reactions and suicidal ideation during one year of the COVID-19 pandemic in patients with severe mental disorders

    Schizophrenia Research

  3. Psychological impact of the COVID-19 pandemic and lockdown in a Spanish sample with anxiety disorder: sex differences

    Actas espanolas de psiquiatria, Vol. 51, Núm. 2, pp. 65-75

  4. Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study

    European Neuropsychopharmacology, Vol. 67, pp. 53-65

  5. Structural covariance predictors of clinical improvement at 2-year follow-up in first-episode psychosis

    Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 120

  6. What factors should we modify to promote high functioning and prevent functional decline in people with schizophrenia?

    Frontiers in Psychiatry, Vol. 14

2022

  1. Does COVID-19 psychological fatigue exist? Results of three online cross-sectional studies conducted in Spain from April 2020 to March 2021

    Journal of Global Health, Vol. 12

  2. Early Impact of the COVID-19 Outbreak on Sleep in a Large Spanish Sample

    Behavioral Sleep Medicine, Vol. 20, Núm. 3, pp. 100-115

  3. Endocrine biomarkers related to sleep-wake cycle and sleep disturbances in patients with bipolar disorder: A systematic review

    European Journal of Psychiatry, Vol. 36, Núm. 4, pp. 223-229

  4. Epigenetic clocks in relapse after a first episode of schizophrenia

    Schizophrenia, Vol. 8, Núm. 1

  5. Is it possible to stage schizophrenia? A systematic review

    Translational Psychiatry, Vol. 12, Núm. 1

  6. Searching for bridges between psychopathology and real-world functioning in first-episode psychosis: A network analysis from the OPTiMiSE trial

    European Psychiatry, Vol. 65, Núm. 1, pp. 1-10